Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[Treatment of lupus-prone mice with a dual inhibitor of TLR7 and TLR9 leads to reduction of autoantibody production and amelioration of disease symptoms.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP679422.RAqFrCij3wluosP10q2Zgs8Yl5sVQ-gwlnIKodNEu_6rE130_assertion description "[Treatment of lupus-prone mice with a dual inhibitor of TLR7 and TLR9 leads to reduction of autoantibody production and amelioration of disease symptoms.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP679422.RAqFrCij3wluosP10q2Zgs8Yl5sVQ-gwlnIKodNEu_6rE130_provenance.
• NP470684.RARcoewtAfp9FNozKK059Qq1wK0oQ3pLfzHfZ94jtjh4Y130_assertion description "[Treatment of lupus-prone mice with a dual inhibitor of TLR7 and TLR9 leads to reduction of autoantibody production and amelioration of disease symptoms.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP470684.RARcoewtAfp9FNozKK059Qq1wK0oQ3pLfzHfZ94jtjh4Y130_provenance.
• NP903900.RABMKvMpcgvPNCgA98Y9RABPZk8Gq4fHBb5nqRLj1zjbc130_assertion description "[Treatment of lupus-prone mice with a dual inhibitor of TLR7 and TLR9 leads to reduction of autoantibody production and amelioration of disease symptoms.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP903900.RABMKvMpcgvPNCgA98Y9RABPZk8Gq4fHBb5nqRLj1zjbc130_provenance.
• NP903967.RADJODmjJnWwD5kkpkarnSvfcqviTnFFCZaMwbnrGNuck130_assertion description "[Treatment of lupus-prone mice with a dual inhibitor of TLR7 and TLR9 leads to reduction of autoantibody production and amelioration of disease symptoms.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP903967.RADJODmjJnWwD5kkpkarnSvfcqviTnFFCZaMwbnrGNuck130_provenance.
• NP641847.RA_GfNx5sgBV9Fp2WVRNcdBajYaFji0udd5zW3VGO8GaI130_assertion description "[Treatment of lupus-prone mice with a dual inhibitor of TLR7 and TLR9 leads to reduction of autoantibody production and amelioration of disease symptoms.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP641847.RA_GfNx5sgBV9Fp2WVRNcdBajYaFji0udd5zW3VGO8GaI130_provenance.
• NP641851.RAxBYByzoXutJXx2ycnaY_q5j5uz3jsWrYxsEBgErsp4g130_assertion description "[Treatment of lupus-prone mice with a dual inhibitor of TLR7 and TLR9 leads to reduction of autoantibody production and amelioration of disease symptoms.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP641851.RAxBYByzoXutJXx2ycnaY_q5j5uz3jsWrYxsEBgErsp4g130_provenance.
• NP641850.RASZIpWl3P4wswJjfMZIVAYc3gLgGamJYykHSbJS2NYcc130_assertion description "[Treatment of lupus-prone mice with a dual inhibitor of TLR7 and TLR9 leads to reduction of autoantibody production and amelioration of disease symptoms.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP641850.RASZIpWl3P4wswJjfMZIVAYc3gLgGamJYykHSbJS2NYcc130_provenance.
• NP641854.RATZo4KwrkNcQAd3VcwmVzf83W_-twMv1rryWpFKe76QA130_assertion description "[Treatment of lupus-prone mice with a dual inhibitor of TLR7 and TLR9 leads to reduction of autoantibody production and amelioration of disease symptoms.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP641854.RATZo4KwrkNcQAd3VcwmVzf83W_-twMv1rryWpFKe76QA130_provenance.
• assertion description "[Treatment of lupus-prone mice with a dual inhibitor of TLR7 and TLR9 leads to reduction of autoantibody production and amelioration of disease symptoms.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Treatment of lupus-prone mice with a dual inhibitor of TLR7 and TLR9 leads to reduction of autoantibody production and amelioration of disease symptoms.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Treatment of lupus-prone mice with a dual inhibitor of TLR7 and TLR9 leads to reduction of autoantibody production and amelioration of disease symptoms.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Treatment of lupus-prone mice with a dual inhibitor of TLR7 and TLR9 leads to reduction of autoantibody production and amelioration of disease symptoms.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Treatment of lupus-prone mice with a dual inhibitor of TLR7 and TLR9 leads to reduction of autoantibody production and amelioration of disease symptoms.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Treatment of lupus-prone mice with a dual inhibitor of TLR7 and TLR9 leads to reduction of autoantibody production and amelioration of disease symptoms.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Treatment of lupus-prone mice with a dual inhibitor of TLR7 and TLR9 leads to reduction of autoantibody production and amelioration of disease symptoms.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Treatment of lupus-prone mice with a dual inhibitor of TLR7 and TLR9 leads to reduction of autoantibody production and amelioration of disease symptoms.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP641848.RAMqM6rjq2aKSSdii2-OjEF8EID5cfoLjmaY8QnvHB-B8130_assertion description "[Treatment of lupus-prone mice with a dual inhibitor of TLR7 and TLR9 leads to reduction of autoantibody production and amelioration of disease symptoms.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP641848.RAMqM6rjq2aKSSdii2-OjEF8EID5cfoLjmaY8QnvHB-B8130_provenance.
• NP909845.RANl2IMjImAsJVhO-Ty0twF3WzlRFNEVJDZEb0JLcORwU130_assertion description "[Treatment of lupus-prone mice with a dual inhibitor of TLR7 and TLR9 leads to reduction of autoantibody production and amelioration of disease symptoms.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP909845.RANl2IMjImAsJVhO-Ty0twF3WzlRFNEVJDZEb0JLcORwU130_provenance.
• NP909855.RAuV8el51jGO2-TJ1f0EOyqiIoOmJQ09YzPogII0eYkNU130_assertion description "[Treatment of lupus-prone mice with a dual inhibitor of TLR7 and TLR9 leads to reduction of autoantibody production and amelioration of disease symptoms.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP909855.RAuV8el51jGO2-TJ1f0EOyqiIoOmJQ09YzPogII0eYkNU130_provenance.
• NP903910.RAsn2pVrHjAzJi4SCf32OQZsrL0L9BqFquYgvlLl2Kvnw130_assertion description "[Treatment of lupus-prone mice with a dual inhibitor of TLR7 and TLR9 leads to reduction of autoantibody production and amelioration of disease symptoms.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP903910.RAsn2pVrHjAzJi4SCf32OQZsrL0L9BqFquYgvlLl2Kvnw130_provenance.
• NP641849.RAjVFr8KPnEPsfmqnqPvK4qdMswOlXgN_V_V5vN8aJBAE130_assertion description "[Treatment of lupus-prone mice with a dual inhibitor of TLR7 and TLR9 leads to reduction of autoantibody production and amelioration of disease symptoms.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP641849.RAjVFr8KPnEPsfmqnqPvK4qdMswOlXgN_V_V5vN8aJBAE130_provenance.
• NP641852.RAkC_w_PJSv-HdImT3A1FLnRQVia-HWKf7zaWdIooiA2w130_assertion description "[Treatment of lupus-prone mice with a dual inhibitor of TLR7 and TLR9 leads to reduction of autoantibody production and amelioration of disease symptoms.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP641852.RAkC_w_PJSv-HdImT3A1FLnRQVia-HWKf7zaWdIooiA2w130_provenance.
• NP641853.RArtuWE3Vrae-zDTXYnEEiqc7CidncNiIWMG__LLn7Pmw130_assertion description "[Treatment of lupus-prone mice with a dual inhibitor of TLR7 and TLR9 leads to reduction of autoantibody production and amelioration of disease symptoms.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP641853.RArtuWE3Vrae-zDTXYnEEiqc7CidncNiIWMG__LLn7Pmw130_provenance.